KLOW Blend (Recovery Blend)

KLOW Blend is a proprietary multi-peptide formulation engineered for recovery and tissue regeneration research, combining KPV, GHK-Cu, BPC-157, and TB-500. The components were selected for their complementary mechanisms -- spanning NF-kB pathway inhibition, VEGF/FGF upregulation, and actin-mediated cell migration -- to enable synergistic investigation of multi-pathway recovery.

Blend Components:

• KPV — 10mg — Anti-inflammatory tripeptide (Lys-Pro-Val) derived from alpha-MSH that inhibits NF-kB activation and reduces pro-inflammatory cytokine expression
• GHK-Cu (Copper Peptide) — 50mg — Tripeptide complex that stimulates collagen synthesis, growth factor expression, and antioxidant enzyme activity
• BPC-157 — 10mg — Pentadecapeptide with demonstrated roles in angiogenesis, VEGF upregulation, and accelerated tissue repair
• TB-500 (Thymosin Beta-4) — 10mg — Actin-binding peptide involved in cell migration, differentiation, and anti-inflammatory signaling

Key Research Findings:

• Component peptides have individually demonstrated 50-70% acceleration in wound closure rates in rodent dermal and musculoskeletal models
• Published studies showed 3-5x upregulation of VEGF and FGF expression in tissue repair assays
• Anti-inflammatory profiling confirmed 40-60% reduction in key pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) in preclinical models
• Growth factor modulation studies reported enhanced satellite cell activation and ~2-fold increase in myofibril regeneration markers

For laboratory and research use only.